SGLT2 inhibitors and molecular signatures of aortic valve remodeling in severe aortic stenosis: the Valve-AS study

31 August 2026 (14:15 - 15:00)
Organised by: Logo
Congress Presentation Part of: Pathophysiology and pharmacotherapy in the development of aortic stenosis Aortic Valve Stenosis ESC2026 Premium Access ESC Congress 2026 European Society of Cardiology